Cost-effectiveness of prophylaxis and treatment of influenza

被引：0
|
作者：
Rychlik, R
Heinen-Kammerer, T
Rusche, H
Piemy, J
Scuffham, P
Zöllner, Y
机构：
[1] Inst Empir Gesundheitsokonom, D-51399 Burscheid, Germany
[2] Ruhr Univ Bochum, D-4630 Bochum, Germany
[3] MAPI Values, Frankreich, Germany
[4] Univ York, York YO10 5DD, N Yorkshire, England
[5] Solvay Pharmaceut GmbH, Hannover, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2003年 / 128卷 / 43期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2267 / 2270
页数：4
相关论文
共 50 条
  • [11] Influenza cost and cost-effectiveness studies globally - A review
    Peasah, Samuel K.
    Azziz-Baumgartner, Eduardo
    Breese, Joseph
    Meltzer, Martin I.
    Widdowson, Marc-Alain
    VACCINE, 2013, 31 (46) : 5339 - 5348
  • [12] Cost-effectiveness and value of information analyses of neuraminidase inhibitors for the treatment of influenza
    Wailoo, Allan J.
    Sutton, Alexander J.
    Cooper, Nicola J.
    Turner, David A.
    Abrams, Keith R.
    Brennan, Alan
    Nicholson, Karl G.
    VALUE IN HEALTH, 2008, 11 (02) : 160 - 171
  • [13] Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults
    Muennig, PA
    Khan, K
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (11) : 1879 - 1885
  • [14] COST-EFFECTIVENESS COMPARISON OF BALOXAVIR MARBOXIL AND LANINAMIVIR FOR THE TREATMENT OF INFLUENZA IN JAPAN
    Skrzeczek, A.
    Ikeoka, H.
    Hirotsu, N.
    Ansaripour, A.
    Aballea, S.
    Onishi, Y.
    Hill, M.
    Igarashi, A.
    VALUE IN HEALTH, 2018, 21 : S228 - S228
  • [15] Cost-effectiveness of baloxavir marboxil compared to laninamivir for the treatment of influenza in Japan
    Skrzeczek, Aleksandra
    Ikeoka, Hidetoshi
    Hirotsu, Nobuo
    Ansaripour, Amir
    Aballea, Samuel
    Onishi, Yoshie
    Hill, Mark
    Igarashi, Ataru
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (02) : 296 - 305
  • [16] Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis
    Rothberg, MB
    Rose, DN
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 (01): : 68 - 77
  • [17] A cost-effectiveness analysis of stress ulcer prophylaxis
    Schupp, KN
    Schrand, LM
    Mutnick, AH
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (05) : 631 - 635
  • [18] Cost-effectiveness of antiepileptic drugs in migraine prophylaxis
    Adelman, JU
    Adelman, LC
    Von Seggern, R
    HEADACHE, 2002, 42 (10): : 978 - 983
  • [19] COST-EFFECTIVENESS OF VENOUS THROMBOEMBOLISM PROPHYLAXIS IN SURGERY
    BERGQVIST, D
    EUROPEAN JOURNAL OF SURGERY, 1994, : 49 - 53
  • [20] MORE ON ANTIBIOTIC PROPHYLAXIS COST-EFFECTIVENESS response
    Skaar, Daniel D.
    Kuntz, Karen M.
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2016, 147 (04): : 231 - 231
12345